Wednesday, 18 May 2022

Thermo Fisher Scientific unveils QualTrak Biopharma qPCR Solutions

11 May 2022 | News

The new launch will help to streamline biologics development and compliance

Image credit: https://www.businesswire.com

Image credit: https://www.businesswire.com

Thermo Fisher Scientific has launched a new collection of qPCR biopharma offerings to help accelerate drug development to meet growing demand for novel biologics.

 

The QualTrak comprehensive suite of qPCR tools consists of a premium selection of trusted Applied Biosystems solutions, including QuantStudio 6 and 7 Pro Real-Time PCR Systems and TaqMan and TaqPath master mixes and assays, to consistently and accurately support the biopharma industry from discovery to post-approval manufacturing. 

 

QualTrak solutions come with readily available compliance documentation to reduce the time required to comply with internal quality systems and regulatory requirements. The carefully curated selection of high-quality qPCR master mixes, assays, instruments, and software are backed by world-class service and support to help simplify drug filings.

 

To support post-discovery steps such as manufacturing QC and biodistribution where reliable results and regulatory compliance are critical, QualTrak TaqPath master mixes and assays are manufactured at an ISO 13485-certified, US Food and Drug Administration (FDA) registered facility that adheres to cGMP manufacturing requirements and demonstrates exceptional lot-to-lot consistency.

 

 

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account